Podcast appearances and mentions of Maria T Abreu

In this podcast episode, Maria Abreu, MD, current president of the AGA, discusses the unique upbringing of health care professionals who are children of immigrants, formal versus on-the-job leadership training and more. •    Intro :24 •    The interview/about Abreu :31 •    Can you tell us about where you grew up and the impact your family had on the work you're doing now? :54 •    Chey and Abreu on the profile in Gastroenterology in May 2024, which announced Abreu as the current AGA president and summarized her personal and professional life. 3:08 •    Abreu on her father's involvement with the Bay of Pigs invasion in Cuba.  7:00 •    Chey and Abreu on the impact of an upbringing as children of immigrants. 12:02 •    How did you get interested in GI, specifically in IBD?  13:00 •    When did it become apparent to you that you were interested in more than traditional academia and clinical medicine, and wanted to inspire and have a broader impact? 17:37 •    What would you say to a younger physician or someone earlier in their career about formal leadership training versus on-the-job training? […] Do you think this generation needs formal training in how to manage people as health care becomes more complex? 21:11 •    Do you think that the future of academia and the phenotype of who is going to lead in academic divisions will change? 28:40 •    What are your priorities during your presidential year at AGA? 34:24 •    What have you learned so far as president of the AGA? Has anything struck you as surprising? 42:03 •    Thank you, Maria 44:12 •    Thanks for listening 44:45 Maria T. Abreu, MD, is the current president of the American Gastroenterological Association. She is the fifth woman to lead AGA as president and the association's first Latino president. Dr. Abreu currently serves as the Martin Kalser Endowed Chair of Gastroenterology; professor of medicine, microbiology and immunology; and director of the Crohn's and Colitis Center at the University of Miami.   We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Abreu, follow @ibddocmaria on X. Disclosures: Berry and Chey report no relevant financial disclosures. Abreu reports receiving consultant fees from serving on pharmaceutical advisory boards.

Host: Neilanjan Nandi, MD Guest: Maria T. Abreu, MD Environmental factors can affect many different aspects of a patient’s heath, but how do these factors play a role in developing inflammatory bowel disorders, or IBD? Tune in to hear Dr. Neil Nandi and Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, discuss the role of environmental factors in patients at risk of developing IBD.

Host: Neilanjan Nandi, MD Guest: Maria T. Abreu, MD Diet is a common concern for many patients with inflammatory bowel disorders. How can we best guide our patients on the influence of diet? Dr. Neil Nandi is joined by Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, to discuss the impact of diet on ulcerative colitis.

Host: Matt Birnholz, MD Guest: Maria T. Abreu, MD As emerging data supports the idea that patients with IBD can be managed by focusing on the microbiome, discussing dietary needs, and using cognitive behavioral therapy, it’s important that providers are attentive to the changing paradigms. During the 2020 Crohn’s and Colitis Foundation Congress, Dr. Maria Abreu leverages her triple-threat perspective on bench research, clinical research, and clinical care to share how we can improve care for patients with IBD.

Host: Matt Birnholz, MD Guest: Maria T. Abreu, MD As emerging data supports the idea that patients with IBD can be managed by focusing on the microbiome, discussing dietary needs, and using cognitive behavioral therapy, it’s important that providers are attentive to the changing paradigms. During the 2020 Crohn’s and Colitis Foundation Congress, Dr. Maria Abreu leverages her triple-threat perspective on bench research, clinical research, and clinical care to share how we can improve care for patients with IBD.

Host: Brent Polk, MD, AGAF Guest: Maria T. Abreu, MD Sit in on the conversation between the chair and co-chair of the Crohn’s & Colitis Congress Dr. Brent Polk and Dr. Maria Abreau, as they discuss highlights from the second annual conference held in Las Vegas and why this meeting is so important for clinicians and scientists alike.

Host: Maria T. Abreu, MD Guest: Michael Rosen, MD, MSCI Dr. Maria Abreu and the Medical Director of Schubert-Martin Inflammatory Bowel Disease Center Dr. Michael Rosen discuss one of the sessions at the second annual Crohn’s & Colitis Congress, entitled “Environmental Triggers and Stemming the Rising Tide of IBD.”

Host: Brent Polk, MD, AGAF Guest: Maria T. Abreu, MD Sit in on the conversation between the chair and co-chair of the Crohn’s & Colitis Congress Dr. Brent Polk and Dr. Maria Abreau, as they discuss highlights from the second annual conference held in Las Vegas and why this meeting is so important for clinicians and scientists alike.

Host: Maria T. Abreu, MD Guest: Michael Rosen, MD, MSCI Dr. Maria Abreu and the Medical Director of Schubert-Martin Inflammatory Bowel Disease Center Dr. Michael Rosen discuss one of the sessions at the second annual Crohn’s & Colitis Congress, entitled “Environmental Triggers and Stemming the Rising Tide of IBD.”

Host: Brent Polk, MD, AGAF Guest: Maria T. Abreu, MD Sit in on the conversation between the chair and co-chair of the Crohn’s & Colitis Congress Dr. Brent Polk and Dr. Maria Abreau, as they discuss highlights from the second annual conference held in Las Vegas and why this meeting is so important for clinicians and scientists alike.

Host: Maria T. Abreu, MD Guest: Michael Rosen, MD, MSCI Dr. Maria Abreu and the Medical Director of Schubert-Martin Inflammatory Bowel Disease Center Dr. Michael Rosen discuss one of the sessions at the second annual Crohn’s & Colitis Congress, entitled “Environmental Triggers and Stemming the Rising Tide of IBD.”

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.

Guest: Maria T. Abreu, MD Host: Jay Goldstein, MD Dr. Maria Abreu, professor of medicine and chief of the division of gastroenterology at the University of Miami Miller School of Medicine, joins host Dr. Jay Goldstein to discuss inflammatory bowel disease, or IBD, and women's reproductive health. Does inflammatory bowel disease, or IBD, affect female fertility? What influence does IBD have on the course of pregnancy, and how does pregnancy, in turn, affect the natural history of IBD? Which medicines used to treat IBD are safe to use during pregnancy, and for new mothers who are nursing? Tune in to hear a discussion of these questions and more.

Host: Jay Goldstein, MD Guest: Maria T. Abreu, MD Dr. Maria Abreu, professor of medicine and chief of the division of gastroenterology at the University of Miami Miller School of Medicine, joins host Dr. Jay Goldstein to discuss inflammatory bowel disease, or IBD, and women's reproductive health. Does inflammatory bowel disease, or IBD, affect female fertility? What influence does IBD have on the course of pregnancy, and how does pregnancy, in turn, affect the natural history of IBD? Which medicines used to treat IBD are safe to use during pregnancy, and for new mothers who are nursing? Tune in to hear a discussion of these questions and more.